Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2509-2723
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans ; volume:43 ; number:5 ; day:11 ; month:10 ; year:2021 ; pages:2321-2331 ; date:10.2021
GeroScience ; 43, Heft 5 (11.10.2021), 2321-2331, 10.2021

Creator
Vályi-Nagy, István
Matula, Zsolt
Gönczi, Márton
Tasnády, Szabolcs
Bekő, Gabriella
Réti, Marienn
Ajzner, Éva
Uher, Ferenc
Contributor
SpringerLink (Online service)

DOI
10.1007/s11357-021-00471-6
URN
urn:nbn:de:101:1-2022012719222658344797
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Vályi-Nagy, István
  • Matula, Zsolt
  • Gönczi, Márton
  • Tasnády, Szabolcs
  • Bekő, Gabriella
  • Réti, Marienn
  • Ajzner, Éva
  • Uher, Ferenc
  • SpringerLink (Online service)

Other Objects (12)

Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2

Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2

Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)

Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients

P04-21. Different human serum antibody profiles elicited by three candidate HIV vaccines using different immunization approaches

P04-21. Different human serum antibody profiles elicited by three candidate HIV vaccines using different immunization approaches

Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)

Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)

Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines

Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2

Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community

Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community

Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand

Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand

Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series

Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series

Pfizer

Sonstiges

Pfizer

Advances in antibody-based HIV-1 vaccines development

Advances in antibody-based HIV-1 vaccines development

Related objects